PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Recruiting now

Conditions studied: Breast Cancer

In brief

The purpose of this study is to provide prospective evidence in the US population of the frequency of skin discoloration and Sentinel Lymph Node detection rate in patients who have recevied Magtrace for Sentinel Lymph Node Biopsy (SLNB) and to evaluate the impact that skin discoloration has on patients when it does occur using patient reported outcome measures.

Key facts

Study ID
NCT06610539
Run by
Endomagnetics Ltd.
People needed
184
Starts
2025-04-22
Expected to finish
2028-11-01
Last updated by the study team
2026-03-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.